Importantly, CYP2E1 activity was increased whereas CYP3A4 activity was decreased in these stearate-loaded cells [24], thus reproducing what has been consistently observed in obese patients with NAFLD [8,18,25,26]. The gene discussed is CYP3A4; the disease is metabolic dysfunction-associated steatotic liver disease.